Quantessence Capital LLC Takes $406,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Quantessence Capital LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,353 shares of the company's stock, valued at approximately $406,000.

Several other large investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $31,000. Tidemark LLC acquired a new position in HCA Healthcare during the fourth quarter valued at $36,000. Activest Wealth Management grew its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the period. Pinnacle Bancorp Inc. boosted its stake in shares of HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after buying an additional 50 shares during the last quarter. Finally, Legacy Investment Solutions LLC raised its position in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HCA. Robert W. Baird reiterated a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Guggenheim began coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. StockNews.com downgraded HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Wednesday, April 9th. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $381.67.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.30% of the stock is owned by insiders.

HCA Healthcare Stock Up 2.2 %

NYSE HCA opened at $324.64 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The business's fifty day simple moving average is $328.71 and its 200-day simple moving average is $333.13. The firm has a market cap of $79.93 billion, a PE ratio of 14.78, a P/E/G ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the company posted $5.90 earnings per share. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.89%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare's payout ratio is 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.